SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001041062-22-000080
Filing Date
2022-02-14
Accepted
2022-02-14 14:08:18
Documents
1
Group Members
ATALAYA CAPITAL MANAGEMENT LPATALAYA SPECIAL PURPOSE INVESTMENT FUND LPCORBIN CAPITAL PARTNERS GP, LLCCORBIN CAPITAL PARTNERS, L.P.CORBIN ERISA OPPORTUNITY FUND, LTD.CORBIN OPPORTUNITY FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 ACM_13G_Biotech_Amend2.txt SC 13G/A 16497
  Complete submission text file 0001041062-22-000080.txt   18299
Mailing Address ONE ROCKEFELLER PLAZA, 32ND FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 32ND FLOOR NEW YORK NY 10020 2122011924
Atalaya Capital Management LP (Filed by) CIK: 0001812285 (see all company filings)

IRS No.: 113774841 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Subject) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92081 | Film No.: 22629329
SIC: 2834 Pharmaceutical Preparations